Showing 6 posts of 6 posts found.


Lupin Healthcare launches Beclu carbon neutral inhalers for asthma treatment

June 22, 2023
Research and Development Asthma & COPD, Beclu, Lupin Healthcare, asthma, carbon neutral, inhaler

UK-based subsidiary of Lupin Limited, Lupin Healthcare, has announced the UK launch of its carbon neutral pressurised metered dose inhalers …


FDA approves GlaxoSmithKline’s Trelegy for treating asthma

September 10, 2020
Research and Development Ashtma, inhaler

The FDA has approved a new indication of Trelegy Ellipta for the treatment of asthma and patients with chronic obstructive …


US approves new generic to treat people suffering from respiratory conditions

August 25, 2020
Manufacturing and Production asthma, inhaler

The FDA has granted Lupin Ltd approval for their generic version of ProAir, which is used to prevent asthma symptoms …


AstraZeneca shocked as inhaler fails to outclass GSK rival in COPD

August 23, 2018
Research and Development AstraZeneca, COPD, GSK, anoro, inhaler, pharma

Researchers at AstraZeneca have been left scratching their heads as new Phase 3b results for its inhaler, Bevespi Aerosphere, posted …


Vectura asthma treatment fails at Phase III

August 30, 2016
Manufacturing and Production, Research and Development asthma, inhaler, phase III, phase III failure, vectura

Respiratory drug specialist Vectura’s asthma treatment Flutiform was unsuccessful in meeting the primary endpoint in its Phase III trial conducted …

Boehringer spends €100 million on inhaler

September 30, 2014
Manufacturing and Production, Sales and Marketing Boehringer, Germany, Spiriva, Striverdi, inhaler, olodaterol, respimat

Boehringer Ingelheim is to spend more than €100 million at its Dortmund site in Germany in order to expand the …

Latest content